BIOELAB has a high-quality R&D team, all the members are highly educated with sufficient working experience. BIOELAB has developed several kinds of semi-auto chemistry analyzer and fully-auto chemistry analyzer.
Till now, our products have been exported to United States, France, Ukraine, Mexico, Peru, Brazil, Ecuador, India, Pakistan, Bangladesh, South Africa etc. up to more than 80 countries and regions. Our products have been recognized as quality ones with good reputation in the market around the world. We’ll keep on looking for good business partners to develop IVD market together in the world.
We pursue precise science, keep the faith of honesty, believe in the management concept of solidarity and innovation, and provide superior products and service for our customers. In the future, we will vigorously throw more energy into research and development work, the range of products will gradually cover all in diagnostic vitro products. We will continue to make efforts to the reach our vision "World Brand, BIOELAB Dream”.
Take the high quality product as the foundation, devote ourselves to build one of the most competitive enterprises in the medical device industry, create the international famous brand.
Create benefits for shareholder, create value for customers, create opportunities for employees, create health for society
Simple, efficient, wise innovation, to be the supreme
Good faith management, customer first, unity, cooperation, excellence
Launched automatic chemistry analyzer with test speed of constant 600 T/H and 800 T/H
Launched semi-auto chemistry analyzer ES-160 and auto chemistry analyzer ES-160
Got registration certificate and proprietary software copyright of all modles。
Got TUV ISO 13485 certificate. Launched fully-auto chemistry analyzer ES-380, ES-480 and semi-auto ones ES-103、ES-105
Got medical device manufacturing license. Developped semi-auto chemistry analyzer ES-100P、ES-102、ES-101C、ES-100C
Semi-auto chemistry analyzer ES-100 & fully-auto chemistry analyzer ES-200 has been successfully developed